SEER commits to an aggressive decarbonization and carbon credit monetization program, starting with its current MV Technology solutions and its planned biocarbon production facilities both domestic and international. BROOMFIELD, CO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Strategic Environmental & Energy Resources, Inc. (SEER) (OTCQB: SENR), a provider of environmental, renewable fuels and industrial waste stream management services, has partnered with DevvStream, Inc., an emerging leader in carbon credit investi ...

DevvStream Enters Biogas Market via Partnership with Methane Renewable Energy LeaderDecember 12, 2024 7:30 AM EST | Source: DevvStream Corp.Carbon Management Program by SEER and DevvStream will be centered around biogas capture and carbon sequestration through biocarbon, or biochar, productionCompanies plan to leverage over 150 existing SEER-affiliate biogas installations across North America with numerous multinational utility companies, food processors, brewers, and agriculture firms as well ...

Company Overview - Seer, Inc. is a leading life sciences company focused on commercializing a new platform for proteomics, specifically the Proteograph Product Suite, which enables deep proteomic analysis at scale [7] - The company has achieved significant recognition, ranking No. 57 on the Deloitte Technology Fast 500 for 2024, with a remarkable revenue growth of 2,440% over the past three years [1][2] Revenue Growth - Seer's revenue growth of 2,440% is attributed to increased adoption of its Proteograph Product Suite and new discoveries by customers in areas such as neurodegenerative diseases, cancer, and metabolic diseases [2] - The average revenue growth for companies in the 2024 Technology Fast 500 was 1,981%, with a median growth rate of 460%, highlighting Seer's exceptional performance [4] Recent Developments - In 2024, Seer launched a technology access center in Europe and saw its Proteograph platform utilized by astronauts on the SpaceX Inspiration4 mission [3] - The company has entered into a co-marketing and sales agreement with Thermo Fisher Scientific, further validating its market position and technological advancements [3] Technology Fast 500 Criteria - To qualify for the Deloitte Technology Fast 500, companies must have proprietary intellectual property or technology that contributes to a majority of their operating revenues, with base-year revenues of at least $50,000 and current-year revenues of at least $5 million [6]

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor conferences: Guggenheim Inaugural Healthcare Innovation Conference in Boston, MAFireside chat on Monday, November 11th at 11:30 a.m. Eastern TimeCanaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NYFireside chat on Thursday, No ...

Seer, Inc. (SEER) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -17.24%. A quarter ago, it was expected that this company would post a loss of $0.36 per share when it actually produced a loss of $0.35, delivering a surprise of 2.78%.Over the last four quarters, the company has surpassed con ...

Table of Contents Copies to: Title of each class Trading Symbol(s) Name of Exchange on which registered Common Stock, par value $0.00001 SEER Nasdaq Global Select Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tra ...

Seer Reports Third Quarter 2024 Financial Results Growing enthusiasm for Proteograph Product Suite with multiple larger orders from government agencies and continued strong interest in STAC REDWOOD CITY, Calif. Nov 6, 2024 – Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights • Achieved revenue of $4.0 million for the third quarter of 2024 • Ente ...

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a co-marketing and sales agreement with Thermo Fisher Scientific, the world leader in serving science, to jointly promote Seer’s Proteograph™ Product Suite alongside Thermo Scientific Orbitrap Astral™ mass spectrometers. This strategic collaboration aims to accelerate the adoption of innovative proteomic technologies, off ...

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the Proteograph Product Suite’s unique ability to deliver deep proteomic insights that complement and strengthen genomic and other “omic” research at the American Society of Human Genetics (ASHG) 2024 Annual Meeting in Denver, Colo., from Nov. 5-9. Seer will present a CoLab session exploring research breakthroughs from Prog ...

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements at the 23rd Human Proteome Organization (HUPO) World Congress in Dresden, Germany, from October 20-24, 2024. As a HUPO sponsor, Seer will showcase novel findings that are driving the adoption and expansion of proteomic science, demonstrating the unique power of its Proteograph™ Product Suite to accelerate proteomic r ...